Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane, or plasma membrane, is a fundamental biological structure composed of a phospholipid bilayer and associated proteins that acts as a selective barrier for the cell (StatPearls, 2023). It is essential for maintaining cellular homeostasis, facilitating signal transduction via receptors, and managing the transport of ions and molecules through specialized channels and transporters (Alberts et al., 2002). While the membrane itself is a structural entity, its individual components—such as G protein-coupled receptors, ion channels, and specific lipids like cholesterol—are among the most common targets for therapeutic intervention (Nature Reviews Drug Discovery, 2006). Dysregulation of membrane proteins and lipids is central to the pathogenesis of various conditions, including cancer, where receptor overexpression drives uncontrolled growth, and infectious diseases, where pathogens exploit membrane components for entry (Cooper, 2000). Drugs targeting the membrane range from antibiotics that disrupt lipid integrity to biologics that bind specific surface proteins to modulate immune responses or signaling (Papo & Shai, 2005). Because the membrane is fundamental to all cells, therapeutic strategies must carefully balance efficacy against the risk of non-specific toxicity to healthy tissues (StatPearls, 2023).
Drugs interact with membrane components through various mechanisms, including physical disruption of the lipid bilayer, formation of transmembrane pores, modulation of membrane fluidity, and high-affinity binding to integral membrane proteins to inhibit signaling or induce antibody-dependent cellular cytotoxicity (Papo & Shai, 2005; StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane proteins and lipids.